PURA CBD Gummies Backed By U.S. Patent And Research
April 23 2020 - 12:15PM
InvestorsHub NewsWire
Dallas, TX -- April 23, 2020 --
InvestorsHub NewsWire -- Puration, Inc. (USOTC:
PURA) today emphasized that the company’s recent acquisition of the Hemp4mula confections
business includes access to a U.S. Patented cannabis extraction
process and the university medical research behind the patented
extraction process. Puration has the only license of the NCM
Biotech Patented Extraction process. NCM Biotech is focused
on medical research and Puration has access to that research.
“We by no means plan to get into the pharmaceutical business,”
explained Brian Shibley, CEO of Puration. “But we do look forward
to having the ability to back the benefits of our Puration CBD
Gummies and Gum with research.”
See a recent research report on CBD
extracts derived from NCM Biotech’s patented extraction process:
Journal of Cannabis
Research
Puration is working now to rebrand
Hemp4mula and research backed benefits are intended to be an
instrumental component of the new
branding.
For more information on Puration,
visit http://www.purationinc.com
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not occur.
These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat,
cure, or prevent any disease.
Contact:
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800)
861-1350
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puration (CE) (USOTC:PURA)
Historical Stock Chart
From Sep 2023 to Sep 2024